Increase in Plasma Concentrations of Geranylgeranoic Acid after Turmeric Tablet Intake by Healthy Volunteers
Open Access
- 1 January 2010
- journal article
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 46 (3) , 252-258
Abstract
Geranylgeranoic acid (GGA) is one of the most potent cancer-preventive acyclic retinoids. GGA has been shown to induce cell death in human hepatoma-derived HuH-7 cells. We have recently reported the natural occurrence of GGA and its related compounds in several medicinal herbs such as turmeric, basil, rosehip, cinnamon and others [Shidoji and Ogawa, J. Lipid Res., 45: 1092-1103, 2004]. In the present study, we performed oral administration of turmeric tablets to healthy volunteers in order to investigate bioavailability of natural GGA. By using liquid chromatography/mass spectrometry, authentic GGA was eluted at a retention time of around 18 min as a negative ion of m/z 303.4. With healthy volunteers, plasma GGA was detected prior to the tablet intake and its concentrations were increased at 2 h after its intake and maintained at higher level until 4 h, suggesting an efficient bioavailability of preformed GGA in the turmeric tablets through oral administration. These results indicated that GGA in the turmeric tablet was absorbed as an intact form from intestinal mucosa. The present study provides a clue to conduct a research for cancer preventive roles of GGA in a number of spices.Keywords
This publication has 16 references indexed in Scilit:
- Rational diagnostic strategy for Zellweger syndrome spectrum patientsEuropean Journal of Human Genetics, 2009
- Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disordersJournal of Lipid Research, 2008
- The uptake and distribution of coenzyme Q(10)Mitochondrion, 2007
- Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductaseCarcinogenesis, 2005
- Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbsJournal of Lipid Research, 2004
- Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular CarcinomaNew England Journal of Medicine, 1999
- Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular CarcinomaNew England Journal of Medicine, 1996
- Induction of Apoptosis by Acyclic Retinoid in the Human Hepatoma-Derived Cell Line, HuH-7Biochemical and Biophysical Research Communications, 1995
- Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell linesMolecular Carcinogenesis, 1994
- Acyclic retinoids and cancer chemopreventionPure and Applied Chemistry, 1991